Skip to main content

Ault Milton C III's Form 4/A amendment

Amended

Alzamend Neuro, Inc. (ALZN) · filed Jul 15, 2021

Accession no.
0001214659-21-007541
Filed
Jul 15, 2021
Trade date
Jul 12-14, 2021
Filing delay
3 days
Rule 10b5-1 plan
Not on the form (before 2023)
Original filed
Jul 14, 2021

This filing lists 3 non-derivative transactions. Open-market purchases total $89.1K. It was filed 3 days after the trade.

This amendment replaces 0001214659-21-007504 (filed Jul 14, 2021).

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
Ault Milton C IIICIK 000121250210% Owner

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
Jul 12, 2021Common StockPPurchaseAcquired+8,100$6.15F1+$49,8155,314,155Indirect
Jul 13, 2021Common StockPPurchaseAcquired+900$6.26F3+$5,6345,315,055Indirect
Jul 14, 2021Common StockPPurchaseAcquired+5,500$6.12F5+$33,6605,320,555Indirect

Footnotes and remarks

Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.

F1

The common stock was purchased by the reporting person in open market transactions on the transaction date, with a volume weighted average purchase price of $6.1496. The range of purchase prices on the transaction date was $5.92 to $6.22 per share. The reporting person undertakes to provide, upon request by the SEC staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased at each price.

Referenced by the price of 1 transaction in Table I.

F2

Digital Power Lending, LLC ("DPL") is a wholly-owned subsidiary of Ault Global Holdings, Inc. ("AGH"). Mr. Ault, the Executive Chairman of AGH, is deemed to have voting and investment power with respect to the securities held of record by DPL.

F3

The common stock was purchased by the reporting person in open market transactions on the transaction date, with a volume weighted average purchase price of $6.2633. The range of purchase prices on the transaction date was $6.19 to $6.32 per share. The reporting person undertakes to provide, upon request by the SEC staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased at each price.

Referenced by the price of 1 transaction in Table I.

F4

The original Form 4 filed on July 14, 2021, is amended by this Form 4 amendment to correct an error in the amount of shares from "5,000" to "5,500".

F5

The original Form 4 filed on July 14, 2021, is amended by this Form 4 amendment to correct an error in the Price from "$6.7374" to "6.1249". The common stock was purchased by the reporting person in open market transactions on the transaction date, with a volume weighted average purchase price of $6.1249. The range of purchase prices on the transaction date was $5.86 to $6.75 per share. The reporting person undertakes to provide, upon request by the SEC staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased at each price.

Referenced by the price of 1 transaction in Table I.

F6

The original Form 4 filed on July 14, 2021, is amended by this Form 4 amendment to correct an error in the amount of shares from "5,320,055" to "5,320,555".

F7

Mr. Ault has sole voting and investment power with respect to the securities held of record by Ault Life Sciences, Inc.

F8

Mr. Ault has sole voting and investment power with respect to the securities held of record by Ault Life Sciences Fund, LLC.

Read the full filing on SEC EDGAR (opens in a new tab)